Cargando…

Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19

Detalles Bibliográficos
Autores principales:	Poignon, C., Blaize, M., Vezinet, C., Lampros, A., Monsel, A., Fekkar, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326463/ https://www.ncbi.nlm.nih.gov/pubmed/32619736 http://dx.doi.org/10.1016/j.cmi.2020.06.026

Ejemplares similares

Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU
por: Fekkar, Arnaud, et al.
Publicado: (2021)

Fungal Infection during COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
por: Fekkar, Arnaud, et al.
Publicado: (2020)

Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
por: Blaize, Marion, et al.
Publicado: (2020)

Invasive fusariosis in a critically ill patient with severe COVID-19 pneumonia: A case report
por: Barberis, Fernanda, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis in an immunocompetent patient with severe dengue fever
por: Pradhan, Birendra, et al.
Publicado: (2014)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

Invasive Fusariosis in Patients with Hematologic Diseases
por: Nucci, Marcio, et al.
Publicado: (2021)

Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
por: Lamoth, Frederic, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19
por: Benedetti, María Fernanda, et al.
Publicado: (2022)

COVID-19–related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis
por: Blaize, Marion, et al.
Publicado: (2020)

Low total cholesterol blood level is correlated with pulmonary severity in COVID-19 critical ill patients
por: Ressaire, Quentin, et al.
Publicado: (2020)

Airborne transmission of invasive fusariosis in patients with hematologic malignancies
por: Moretti, Maria Luiza, et al.
Publicado: (2018)

Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
por: Pérez-Nadales, Elena, et al.
Publicado: (2021)

Severe Babesiosis in Immunocompetent Man, Spain, 2011
por: Gonzalez, Luis M., et al.
Publicado: (2014)

Increased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil
por: Nucci, Marcio, et al.
Publicado: (2013)

Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
por: Nucci, Marcio, et al.
Publicado: (2014)

Occurrence of Candidemia in Patients with COVID-19 Admitted to Five ICUs in France
por: Blaize, Marion, et al.
Publicado: (2022)

Not only pulmonary rehabilitation for critically ill patients with COVID-19
por: Estraneo, Anna, et al.
Publicado: (2020)

Pulmonary embolism among critically ill patients with ARDS due to COVID-19
por: Soumagne, T., et al.
Publicado: (2020)

Severe neurological complications in critically ill COVID-19 patients
por: Notz, Quirin, et al.
Publicado: (2020)

Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience
por: Stempel, Jessica M., et al.
Publicado: (2015)

950 An Outbreak of Invasive Fusariosis in a Children's Cancer Hospital
por: Litvinov, Nadia, et al.
Publicado: (2014)

Multisystemic fusariosis with fulminant evolution()()
por: Turra, Nelson, et al.
Publicado: (2020)

Severe cutaneous fusariosis in a patient with refractory acute myeloid leukemia
por: Chen, Benjamin C., et al.
Publicado: (2023)

High prevalence of heterotopic ossification in critically ill patients with severe COVID-19
por: Stoira, Elisa, et al.
Publicado: (2021)

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
por: Fekkar, Arnaud, et al.
Publicado: (2021)

Risk factors for early invasive fungal disease in critically ill patients
por: Sai Saran, P. V., et al.
Publicado: (2016)

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
por: Alkhazraji, Sondus, et al.
Publicado: (2020)

Pulmonary histoplasmosis presenting with a halo sign on CT in an immunocompetent patient
por: Pereira, Graziella Hanna, et al.
Publicado: (2013)

Pulmonary cryptococcoma presenting as endobronchial mass mimicking malignancy in immunocompetent host
por: Gupta, Hemant R, et al.
Publicado: (2015)

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020)

Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19
por: Zha, Lei, et al.
Publicado: (2021)

Recent Advances in the Treatment of Scedosporiosis and Fusariosis
por: McCarthy, Matthew W., et al.
Publicado: (2018)

Critically ill patients with COVID-19 and candidaemia: We must keep this in mind
por: Agrifoglio, A., et al.
Publicado: (2020)

Outcome of non-invasive ventilation in COVID-19 critically ill patients: A Retrospective observational Study
por: Mukhtar, Ahmed, et al.
Publicado: (2020)

‘High prevalence of heterotopic ossification in critically ill patients with severe COVID-19’ – Author's reply
por: Stoira, Elisa, et al.
Publicado: (2021)

Fusariosis: An Invasive Fungal Disease in a Neutropenic Patient With Acute Myeloid Leukemia
por: Asiimwe, Denis D, et al.
Publicado: (2022)

Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient
por: Arranz, Natàlia, et al.
Publicado: (2022)

Critical illness myopathy as a consequence of Covid-19 infection
por: Tankisi, H., et al.
Publicado: (2020)

C-Reactive protein role in assessing COVID-19 deceased geriatrics and survivors of severe and critical illness
por: Nori, Wassan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u4jtmv7js72mbdcj4fvlqh8ct7